Here we show that pharmacological inhibition of IKKβ in primary human lung epithelial cells transformed by KRAS, as well as KRAS mutant lung cancer cell lines, inhibits NF-κB activity and reduces cell growth. This evidence concerns the gene KRAS and lung carcinoma.